<?xml version="1.0" encoding="UTF-8"?>
<p>A novel coronavirus strain causing fatal respiratory syndrome was reported in late 2019. In January 2020, it was revealed that it belongs to the beta-coronaviruses, sharing similarity to SARS-coronaviruses, and that its spike protein interacts strongly with the human angiotensin-converting enzyme 2 (ACE2) receptor (
 <xref rid="ref25" ref-type="bibr">Dhama et al., 2020</xref>; 
 <xref rid="ref79" ref-type="bibr">Xu et al., 2020</xref>). On March 11, the 
 <xref rid="ref77" ref-type="bibr">World Health Organization (WHO, 2020)</xref> announced that the spread of the new coronavirus had reached a pandemic stage. To date (23.10.2020), there are more than 40 million confirmed cases of the disease in the world, while there is still no effective treatment for the disease. In this regard, the search for cures for this disease is undoubtedly relevant and significant. Plant-based medicine is attracting a lot of attention today, since medicinal plants are enriched with variety of secondary metabolites including those with antiviral properties (
 <xref rid="ref31" ref-type="bibr">Gurib-Fakim, 2006</xref>; 
 <xref rid="ref2" ref-type="bibr">Adedeji and Sarafianos, 2014</xref>; 
 <xref rid="ref24" ref-type="bibr">Dhama et al., 2018</xref>; 
 <xref rid="ref26" ref-type="bibr">Divya et al., 2020</xref>; 
 <xref rid="ref76" ref-type="bibr">Vellingiri et al., 2020</xref>). About, a third of FDA-approved drugs over the past 20 years are based on natural products or their derivatives (
 <xref rid="ref10" ref-type="bibr">Carter, 2011</xref>).
</p>
